Last reviewed · How we verify

Propofol for light sedation

Centre de recherche du Centre hospitalier universitaire de Sherbrooke · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Propofol for light sedation is a Small molecule drug developed by Centre de recherche du Centre hospitalier universitaire de Sherbrooke. It is currently FDA-approved.

Propofol is a small molecule that acts as a positive allosteric modulator of the GABA-A receptor, an anion channel. It is used for light sedation, as indicated by clinical trials.

At a glance

Generic namePropofol for light sedation
SponsorCentre de recherche du Centre hospitalier universitaire de Sherbrooke
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Propofol for light sedation

What is Propofol for light sedation?

Propofol for light sedation is a Small molecule drug developed by Centre de recherche du Centre hospitalier universitaire de Sherbrooke.

Who makes Propofol for light sedation?

Propofol for light sedation is developed and marketed by Centre de recherche du Centre hospitalier universitaire de Sherbrooke (see full Centre de recherche du Centre hospitalier universitaire de Sherbrooke pipeline at /company/centre-de-recherche-du-centre-hospitalier-universitaire-de-sherbrooke).

What development phase is Propofol for light sedation in?

Propofol for light sedation is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing